Global Breast Imaging Market Worth USD 4.6 Billion by 2023
By MedImaging International staff writers Posted on 06 Feb 2019 |
The global breast imaging market is projected to grow at a CAGR of 8.0% from USD 3.1 billion in 2018 to reach USD 4.6 billion by 2023, driven mainly by technological advancements and rising incidence of breast cancer. The market growth will be further aided by the rising adoption of advanced techniques for breast cancer screening and increasing government and private investments for improving breast cancer care.
These are the latest findings of MarketsandMarkets (Northbrook, IL, USA), a global market research company. On the basis of technology, the ionizing breast imaging technology segment is expected to account for the largest share of the breast imaging market during the forecast period, primarily due to technological advancements in ionizing breast imaging technologies and rising awareness about early screening and diagnosis of breast cancer. Based on type, the 3D breast tomosynthesis segment is expected to register the highest CAGR during the forecast period, driven by the growing demand for advanced screening technologies and increasing regulatory approvals for 3D breast tomosynthesis systems.
Geographically, North American accounted for the largest share of the global breast imaging market in 2018, due to rising incidence of breast cancer, easy accessibility and high adoption of advanced diagnostic technologies (owing to the significant per capita annual healthcare expenditure in the US and Canada), and rapidly increasing geriatric population in the region.
Related Links:
MarketsandMarkets
These are the latest findings of MarketsandMarkets (Northbrook, IL, USA), a global market research company. On the basis of technology, the ionizing breast imaging technology segment is expected to account for the largest share of the breast imaging market during the forecast period, primarily due to technological advancements in ionizing breast imaging technologies and rising awareness about early screening and diagnosis of breast cancer. Based on type, the 3D breast tomosynthesis segment is expected to register the highest CAGR during the forecast period, driven by the growing demand for advanced screening technologies and increasing regulatory approvals for 3D breast tomosynthesis systems.
Geographically, North American accounted for the largest share of the global breast imaging market in 2018, due to rising incidence of breast cancer, easy accessibility and high adoption of advanced diagnostic technologies (owing to the significant per capita annual healthcare expenditure in the US and Canada), and rapidly increasing geriatric population in the region.
Related Links:
MarketsandMarkets
Latest Industry News News
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures
- Global Contrast Enhanced Ultrasound Market Driven by Demand for Early Detection of Chronic Diseases